{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "update_type": "Revised",
      "initial_posting_date": "07/18/2023",
      "package_ndc": "0169-2800-15",
      "generic_name": "Liraglutide Injection",
      "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Liraglutide+Injection&st=d",
      "contact_info": "833-493-4689",
      "availability": "Limited Availability",
      "related_info": "Product will be available until discontinuation in January 2027",
      "openfda": {
        "application_number": [
          "NDA206321"
        ],
        "brand_name": [
          "SAXENDA"
        ],
        "generic_name": [
          "LIRAGLUTIDE"
        ],
        "manufacturer_name": [
          "Novo Nordisk Pharmaceutical Industries, LP"
        ],
        "product_ndc": [
          "0169-2800"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "LIRAGLUTIDE"
        ],
        "rxcui": [
          "1598268",
          "2735350"
        ],
        "spl_id": [
          "7e183945-550d-4b6a-bf4e-300193517cac"
        ],
        "spl_set_id": [
          "3946d389-0926-4f77-a708-0acb8153b143"
        ],
        "package_ndc": [
          "0169-2800-15",
          "0169-2800-90",
          "0169-2800-97"
        ],
        "nui": [
          "N0000178480",
          "M0160181",
          "N0000020058"
        ],
        "pharm_class_epc": [
          "GLP-1 Receptor Agonist [EPC]"
        ],
        "pharm_class_cs": [
          "Glucagon-Like Peptide 1 [CS]"
        ],
        "pharm_class_moa": [
          "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
        ],
        "unii": [
          "839I73S42A"
        ]
      },
      "update_date": "08/25/2026",
      "therapeutic_category": [
        "Endocrinology/Metabolism"
      ],
      "dosage_form": "Injection",
      "presentation": "Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)",
      "company_name": "Novo Nordisk, Inc.",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "status": "Current"
    }
  ]
}